Histotype-tailored neoadjuvant chemotherapy versus standard chemotherapy in patients with high-risk soft-tissue sarcomas (ISG-STS 1001): an international, open-label, randomised, controlled, phase 3, multicentre trial

Autor: Gronchi, Alessandro, Ferrari, Stefano, Quagliuolo, Vittorio, Broto, Javier Martin, Pousa, Antonio Lopez, Grignani, Giovanni, Basso, Umberto, Blay, Jean-Yves, Tendero, Oscar, Beveridge, Robert Diaz, Ferraresi, Virginia, Lugowska, Iwona, Merlo, Domenico Franco, Fontana, Valeria, Marchesi, Emanuela, Donati, Davide Maria, Palassini, Elena, Palmerini, Emanuela, De Sanctis, Rita, Morosi, Carlo, Stacchiotti, Silvia, Bagué, Silvia, Coindre, Jean Michelle, Dei Tos, Angelo Paolo, Picci, Piero, Bruzzi, Paolo, Casali, Paolo Giovanni
Zdroj: In The Lancet Oncology June 2017 18(6):812-822
Databáze: ScienceDirect